Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Operations: 2013-2024

Historic Cash from Operations for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$37.6 million.

  • Armata Pharmaceuticals' Cash from Operations fell 34.87% to -$3.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$10.6 million, marking a year-over-year decrease of 15.61%. This contributed to the annual value of -$37.6 million for FY2024, which is 20.82% up from last year.
  • According to the latest figures from FY2024, Armata Pharmaceuticals' Cash from Operations is -$37.6 million, which was up 20.82% from -$47.4 million recorded in FY2023.
  • Armata Pharmaceuticals' 5-year Cash from Operations high stood at -$18.3 million for FY2020, and its period low was -$47.4 million during FY2023.
  • In the last 3 years, Armata Pharmaceuticals' Cash from Operations had a median value of -$37.6 million in 2024 and averaged -$39.2 million.
  • In the last 5 years, Armata Pharmaceuticals' Cash from Operations slumped by 46.00% in 2023 and then rose by 20.82% in 2024.
  • Over the past 5 years, Armata Pharmaceuticals' Cash from Operations (Yearly) stood at -$18.3 million in 2020, then declined by 29.04% to -$23.6 million in 2021, then slumped by 37.78% to -$32.5 million in 2022, then tumbled by 46.00% to -$47.4 million in 2023, then rose by 20.82% to -$37.6 million in 2024.